278 related articles for article (PubMed ID: 30185652)
41. An Accurate and Comprehensive Clinical Sequencing Assay for Cancer Targeted and Immunotherapies.
Cao J; Chen L; Li H; Chen H; Yao J; Mu S; Liu W; Zhang P; Cheng Y; Liu B; Hu Z; Chen D; Kang H; Hu J; Wang A; Wang W; Yao M; Chrin G; Wang X; Zhao W; Li L; Xu L; Guo W; Jia J; Chen J; Wang K; Li G; Shi W
Oncologist; 2019 Dec; 24(12):e1294-e1302. PubMed ID: 31409745
[TBL] [Abstract][Full Text] [Related]
42. Mutation-Attention (MuAt): deep representation learning of somatic mutations for tumour typing and subtyping.
Sanjaya P; Maljanen K; Katainen R; Waszak SM; ; Aaltonen LA; Stegle O; Korbel JO; Pitkänen E
Genome Med; 2023 Jul; 15(1):47. PubMed ID: 37420249
[TBL] [Abstract][Full Text] [Related]
43. ISOWN: accurate somatic mutation identification in the absence of normal tissue controls.
Kalatskaya I; Trinh QM; Spears M; McPherson JD; Bartlett JMS; Stein L
Genome Med; 2017 Jun; 9(1):59. PubMed ID: 28659176
[TBL] [Abstract][Full Text] [Related]
44. Next-Generation Radiogenomics Sequencing for Prediction of EGFR and KRAS Mutation Status in NSCLC Patients Using Multimodal Imaging and Machine Learning Algorithms.
Shiri I; Maleki H; Hajianfar G; Abdollahi H; Ashrafinia S; Hatt M; Zaidi H; Oveisi M; Rahmim A
Mol Imaging Biol; 2020 Aug; 22(4):1132-1148. PubMed ID: 32185618
[TBL] [Abstract][Full Text] [Related]
45. Correlation of Somatic Genomic Alterations Between Tissue Genomics and ctDNA Employing Next-Generation Sequencing: Analysis of Lung and Gastrointestinal Cancers.
Toor OM; Ahmed Z; Bahaj W; Boda U; Cummings LS; McNally ME; Kennedy KF; Pluard TJ; Hussain A; Subramanian J; Masood A
Mol Cancer Ther; 2018 May; 17(5):1123-1132. PubMed ID: 29500272
[TBL] [Abstract][Full Text] [Related]
46. tarSVM: Improving the accuracy of variant calls derived from microfluidic PCR-based targeted next generation sequencing using a support vector machine.
Gillies CE; Otto EA; Vega-Warner V; Robertson CC; Sanna-Cherchi S; Gharavi A; Crawford B; Bhimma R; Winkler C; ; ; Kang HM; Sampson MG
BMC Bioinformatics; 2016 Jun; 17(1):233. PubMed ID: 27287006
[TBL] [Abstract][Full Text] [Related]
47. Comparing somatic mutation-callers: beyond Venn diagrams.
Kim SY; Speed TP
BMC Bioinformatics; 2013 Jun; 14():189. PubMed ID: 23758877
[TBL] [Abstract][Full Text] [Related]
48. [Lung cancer molecular testing, what role for Next Generation Sequencing and circulating tumor DNA].
Pécuchet N; Legras A; Laurent-Puig P; Blons H
Ann Pathol; 2016 Jan; 36(1):80-93. PubMed ID: 26803564
[TBL] [Abstract][Full Text] [Related]
49. Ensemble-Based Somatic Mutation Calling in Cancer Genomes.
Huang W; Guo YA; Chang MM; Skanderup AJ
Methods Mol Biol; 2020; 2120():37-46. PubMed ID: 32124310
[TBL] [Abstract][Full Text] [Related]
50. Comparison of whole-exome sequencing of matched fresh and formalin fixed paraffin embedded melanoma tumours: implications for clinical decision making.
De Paoli-Iseppi R; Johansson PA; Menzies AM; Dias KR; Pupo GM; Kakavand H; Wilmott JS; Mann GJ; Hayward NK; Dinger ME; Long GV; Scolyer RA
Pathology; 2016 Apr; 48(3):261-6. PubMed ID: 27020503
[TBL] [Abstract][Full Text] [Related]
51. Performance validation of an amplicon-based targeted next-generation sequencing assay and mutation profiling of 648 Chinese colorectal cancer patients.
Wang Y; Liu H; Hou Y; Zhou X; Liang L; Zhang Z; Shi H; Xu S; Hu P; Zheng Z; Liu R; Tang T; Ye F; Liang Z; Bu H
Virchows Arch; 2018 Jun; 472(6):959-968. PubMed ID: 29705968
[TBL] [Abstract][Full Text] [Related]
52. Toward best practice in cancer mutation detection with whole-genome and whole-exome sequencing.
Xiao W; Ren L; Chen Z; Fang LT; Zhao Y; Lack J; Guan M; Zhu B; Jaeger E; Kerrigan L; Blomquist TM; Hung T; Sultan M; Idler K; Lu C; Scherer A; Kusko R; Moos M; Xiao C; Sherry ST; Abaan OD; Chen W; Chen X; Nordlund J; Liljedahl U; Maestro R; Polano M; Drabek J; Vojta P; Kõks S; Reimann E; Madala BS; Mercer T; Miller C; Jacob H; Truong T; Moshrefi A; Natarajan A; Granat A; Schroth GP; Kalamegham R; Peters E; Petitjean V; Walton A; Shen TW; Talsania K; Vera CJ; Langenbach K; de Mars M; Hipp JA; Willey JC; Wang J; Shetty J; Kriga Y; Raziuddin A; Tran B; Zheng Y; Yu Y; Cam M; Jailwala P; Nguyen C; Meerzaman D; Chen Q; Yan C; Ernest B; Mehra U; Jensen RV; Jones W; Li JL; Papas BN; Pirooznia M; Chen YC; Seifuddin F; Li Z; Liu X; Resch W; Wang J; Wu L; Yavas G; Miles C; Ning B; Tong W; Mason CE; Donaldson E; Lababidi S; Staudt LM; Tezak Z; Hong H; Wang C; Shi L
Nat Biotechnol; 2021 Sep; 39(9):1141-1150. PubMed ID: 34504346
[TBL] [Abstract][Full Text] [Related]
53. Implementation of next generation sequencing technology for somatic mutation detection in routine laboratory practice.
Giardina T; Robinson C; Grieu-Iacopetta F; Millward M; Iacopetta B; Spagnolo D; Amanuel B
Pathology; 2018 Jun; 50(4):389-401. PubMed ID: 29752127
[TBL] [Abstract][Full Text] [Related]
54. Performance comparison: exome sequencing as a single test replacing Sanger sequencing.
Fridman H; Bormans C; Einhorn M; Au D; Bormans A; Porat Y; Sanchez LF; Manning B; Levy-Lahad E; Behar DM
Mol Genet Genomics; 2021 May; 296(3):653-663. PubMed ID: 33694043
[TBL] [Abstract][Full Text] [Related]
55.
Zhang N; Shen J; Gou L; Cao M; Ding W; Luo P; Zhang J
Bioengineered; 2022 May; 13(5):11577-11592. PubMed ID: 35531878
[TBL] [Abstract][Full Text] [Related]
56. Measurement of tumor mutational burden (TMB) in routine molecular diagnostics: in silico and real-life analysis of three larger gene panels.
Endris V; Buchhalter I; Allgäuer M; Rempel E; Lier A; Volckmar AL; Kirchner M; von Winterfeld M; Leichsenring J; Neumann O; Penzel R; Weichert W; Glimm H; Fröhling S; Winter H; Herth F; Thomas M; Schirmacher P; Budczies J; Stenzinger A
Int J Cancer; 2019 May; 144(9):2303-2312. PubMed ID: 30446996
[TBL] [Abstract][Full Text] [Related]
57. VariFAST: a variant filter by automated scoring based on tagged-signatures.
Zhang H; Wang K; Zhou J; Chen J; Xu Y; Wang D; Li X; Sun R; Zhang M; Wang Z; Shi Y
BMC Bioinformatics; 2019 Dec; 20(Suppl 22):713. PubMed ID: 31888441
[TBL] [Abstract][Full Text] [Related]
58. Implementation and use of whole exome sequencing for metastatic solid cancer.
Réda M; Richard C; Bertaut A; Niogret J; Collot T; Fumet JD; Blanc J; Truntzer C; Desmoulins I; Ladoire S; Hennequin A; Favier L; Bengrine L; Vincent J; Hervieu A; Dusserre JG; Lepage C; Foucher P; Borg C; Albuisson J; Arnould L; Nambot S; Faivre L; Boidot R; Ghiringhelli F
EBioMedicine; 2020 Jan; 51():102624. PubMed ID: 31923800
[TBL] [Abstract][Full Text] [Related]
59. New Developments and Possibilities in Reanalysis and Reinterpretation of Whole Exome Sequencing Datasets for Unsolved Rare Diseases Using Machine Learning Approaches.
Setty ST; Scott-Boyer MP; Cuppens T; Droit A
Int J Mol Sci; 2022 Jun; 23(12):. PubMed ID: 35743235
[TBL] [Abstract][Full Text] [Related]
60. A simple method to estimate the in-house limit of detection for genetic mutations with low allele frequencies in whole-exome sequencing analysis by next-generation sequencing.
Miura T; Yasuda S; Sato Y
BMC Genom Data; 2021 Feb; 22(1):8. PubMed ID: 33602132
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
